The economic burden of cervical cancer in Eswatini: Societal perspective.
<h4>Background</h4>Cervical cancer imposes considerable economic burden on societies and individuals. There is lack of evidence regarding this from the developing world and particularly from sub-Saharan Africa. Therefore, the study aimed to estimate the societal costs of cervical cancer...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0250113 |
_version_ | 1818825177140559872 |
---|---|
author | Cebisile Ngcamphalala Ellinor Östensson Themba G Ginindza |
author_facet | Cebisile Ngcamphalala Ellinor Östensson Themba G Ginindza |
author_sort | Cebisile Ngcamphalala |
collection | DOAJ |
description | <h4>Background</h4>Cervical cancer imposes considerable economic burden on societies and individuals. There is lack of evidence regarding this from the developing world and particularly from sub-Saharan Africa. Therefore, the study aimed to estimate the societal costs of cervical cancer in Eswatini.<h4>Materials and methods</h4>The cost of illness study (CoI) was applied using national specific clinical and registry data from hospitals, registries and reports to determine the prevalence of cervical intraepithelial neoplasia (CIN) and cervical cancer in Eswatini in 2018. Cost data included direct medical costs (health care utilization in inpatient and outpatient care), direct non-medical costs (patient costs for traveling) and indirect costs based on productivity loss due to morbidity (patient time during diagnosis and treatment) and premature mortality.<h4>Results</h4>The estimated total annual cost for cervical cancer was $19 million (ranging between $14 million and $24 million estimated with lower and upper bounds). Direct cost represented the majority of the costs at 72% ($13.7 million) out of which total pre-cancerous treatment costs accounted for 0.7% ($94,161). The management of invasive cervical cancer was the main cost driver with costs attributable to treatment for FIGO III and FIGO IV representing $1.7 million and $8.7 million respectively. Indirect costs contributed 27% ($5.3 million) out of which productivity loss due to premature mortality represented the majority at 67% ($3.5 million).<h4>Conclusion</h4>The economic burden of cervical cancer in Eswatini is substantial. National public health prevention strategies with prophylactic HPV vaccine and screening for cervical lesions should therefore be prioritized to limit the extensive costs associated with cervical cancer. |
first_indexed | 2024-12-19T00:07:37Z |
format | Article |
id | doaj.art-780611c77d0f494ab2e46df2013dcf60 |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-19T00:07:37Z |
publishDate | 2021-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-780611c77d0f494ab2e46df2013dcf602022-12-21T20:46:07ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01164e025011310.1371/journal.pone.0250113The economic burden of cervical cancer in Eswatini: Societal perspective.Cebisile NgcamphalalaEllinor ÖstenssonThemba G Ginindza<h4>Background</h4>Cervical cancer imposes considerable economic burden on societies and individuals. There is lack of evidence regarding this from the developing world and particularly from sub-Saharan Africa. Therefore, the study aimed to estimate the societal costs of cervical cancer in Eswatini.<h4>Materials and methods</h4>The cost of illness study (CoI) was applied using national specific clinical and registry data from hospitals, registries and reports to determine the prevalence of cervical intraepithelial neoplasia (CIN) and cervical cancer in Eswatini in 2018. Cost data included direct medical costs (health care utilization in inpatient and outpatient care), direct non-medical costs (patient costs for traveling) and indirect costs based on productivity loss due to morbidity (patient time during diagnosis and treatment) and premature mortality.<h4>Results</h4>The estimated total annual cost for cervical cancer was $19 million (ranging between $14 million and $24 million estimated with lower and upper bounds). Direct cost represented the majority of the costs at 72% ($13.7 million) out of which total pre-cancerous treatment costs accounted for 0.7% ($94,161). The management of invasive cervical cancer was the main cost driver with costs attributable to treatment for FIGO III and FIGO IV representing $1.7 million and $8.7 million respectively. Indirect costs contributed 27% ($5.3 million) out of which productivity loss due to premature mortality represented the majority at 67% ($3.5 million).<h4>Conclusion</h4>The economic burden of cervical cancer in Eswatini is substantial. National public health prevention strategies with prophylactic HPV vaccine and screening for cervical lesions should therefore be prioritized to limit the extensive costs associated with cervical cancer.https://doi.org/10.1371/journal.pone.0250113 |
spellingShingle | Cebisile Ngcamphalala Ellinor Östensson Themba G Ginindza The economic burden of cervical cancer in Eswatini: Societal perspective. PLoS ONE |
title | The economic burden of cervical cancer in Eswatini: Societal perspective. |
title_full | The economic burden of cervical cancer in Eswatini: Societal perspective. |
title_fullStr | The economic burden of cervical cancer in Eswatini: Societal perspective. |
title_full_unstemmed | The economic burden of cervical cancer in Eswatini: Societal perspective. |
title_short | The economic burden of cervical cancer in Eswatini: Societal perspective. |
title_sort | economic burden of cervical cancer in eswatini societal perspective |
url | https://doi.org/10.1371/journal.pone.0250113 |
work_keys_str_mv | AT cebisilengcamphalala theeconomicburdenofcervicalcancerineswatinisocietalperspective AT ellinorostensson theeconomicburdenofcervicalcancerineswatinisocietalperspective AT thembagginindza theeconomicburdenofcervicalcancerineswatinisocietalperspective AT cebisilengcamphalala economicburdenofcervicalcancerineswatinisocietalperspective AT ellinorostensson economicburdenofcervicalcancerineswatinisocietalperspective AT thembagginindza economicburdenofcervicalcancerineswatinisocietalperspective |